In the last week, the Pharma industry is up 1.4%, with Eli Lilly up 3.4%. This takes the industry's 12 month performance to a gain of 15%. Looking forward, earnings are forecast to grow by 24% annually.
Has the U.S. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sun, 18 Aug 2024 | US$2.0t | US$362.1b | US$21.8b | 17.3x | 92.2x | 5.6x |
Tue, 16 Jul 2024 | US$2.0t | US$357.7b | US$13.8b | 15.9x | 146.1x | 5.7x |
Thu, 13 Jun 2024 | US$1.9t | US$358.3b | US$14.1b | 15.8x | 138.1x | 5.4x |
Sat, 11 May 2024 | US$1.9t | US$358.2b | US$13.5b | 18.5x | 137.7x | 5.2x |
Mon, 08 Apr 2024 | US$1.9t | US$355.2b | US$22.8b | 24.7x | 82.2x | 5.3x |
Wed, 06 Mar 2024 | US$1.9t | US$355.3b | US$22.5b | 23.4x | 84.5x | 5.3x |
Fri, 02 Feb 2024 | US$1.8t | US$353.0b | US$22.3b | 32x | 80.4x | 5.1x |
Sun, 31 Dec 2023 | US$1.7t | US$375.2b | US$33.8b | 31.9x | 49.9x | 4.5x |
Tue, 28 Nov 2023 | US$1.7t | US$375.1b | US$33.9b | 26x | 48.8x | 4.4x |
Thu, 26 Oct 2023 | US$1.7t | US$382.7b | US$44.7b | 14.9x | 36.9x | 4.3x |
Sat, 23 Sep 2023 | US$1.7t | US$381.8b | US$43.9b | 19.9x | 38.3x | 4.4x |
Mon, 21 Aug 2023 | US$1.8t | US$381.6b | US$44.1b | 18.5x | 40.4x | 4.7x |
Wed, 19 Jul 2023 | US$1.7t | US$392.8b | US$60.2b | 18.9x | 27.6x | 4.2x |
Fri, 16 Jun 2023 | US$1.7t | US$392.8b | US$60.1b | 19.2x | 28.7x | 4.4x |
Sun, 14 May 2023 | US$1.7t | US$392.9b | US$60.4b | 20.4x | 28.7x | 4.4x |
Tue, 11 Apr 2023 | US$1.7t | US$401.3b | US$69.7b | 16.7x | 23.7x | 4.1x |
Thu, 09 Mar 2023 | US$1.5t | US$401.2b | US$69.3b | 16.8x | 22.3x | 3.8x |
Sat, 04 Feb 2023 | US$1.7t | US$402.1b | US$69.9b | 18.2x | 23.7x | 4.1x |
Mon, 02 Jan 2023 | US$1.7t | US$403.7b | US$70.7b | 16.8x | 24.7x | 4.3x |
Wed, 30 Nov 2022 | US$1.7t | US$403.7b | US$70.7b | 16.7x | 24.7x | 4.3x |
Fri, 28 Oct 2022 | US$1.7t | US$404.8b | US$70.8b | 13.6x | 23.6x | 4.1x |
Sun, 25 Sep 2022 | US$1.6t | US$403.0b | US$71.3b | 12.8x | 21.9x | 3.9x |
Tue, 23 Aug 2022 | US$1.6t | US$402.8b | US$70.1b | 14.8x | 23.5x | 4.1x |
Thu, 21 Jul 2022 | US$1.6t | US$393.1b | US$63.6b | 21.5x | 25.9x | 4.2x |
Sat, 18 Jun 2022 | US$1.6t | US$392.5b | US$64.7b | 20.4x | 24.1x | 4x |
Mon, 16 May 2022 | US$1.6t | US$392.5b | US$64.4b | 20.4x | 25.3x | 4.2x |
Wed, 13 Apr 2022 | US$1.7t | US$373.7b | US$60.9b | 22.7x | 27.7x | 4.5x |
Fri, 11 Mar 2022 | US$1.6t | US$373.7b | US$60.4b | 20.4x | 25.8x | 4.2x |
Sun, 06 Feb 2022 | US$1.6t | US$365.5b | US$52.7b | 21.1x | 30x | 4.3x |
Tue, 04 Jan 2022 | US$1.6t | US$361.1b | US$37.8b | 23x | 43.5x | 4.6x |
Thu, 02 Dec 2021 | US$1.5t | US$361.1b | US$38.1b | 23x | 40.2x | 4.2x |
Sat, 30 Oct 2021 | US$1.5t | US$340.9b | US$29.4b | 19.9x | 52.5x | 4.5x |
Mon, 27 Sep 2021 | US$1.5t | US$337.6b | US$25.8b | 22x | 58.3x | 4.5x |
Wed, 25 Aug 2021 | US$1.6t | US$338.5b | US$25.8b | 19.9x | 61.8x | 4.7x |
61.8x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 3.87% | |
Healthcare | 2.09% | |
Pharma | 1.39% | |
Pharma | 1.39% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
LLY Eli Lilly | US$922.12 | 3.4% +US$27.4b | 68.8% | PE113.1x | |
BMY Bristol-Myers Squibb | US$49.36 | 5.7% +US$5.4b | -20.5% | PS2.2x | |
TEVA Teva Pharmaceutical Industries | US$18.26 | 4.8% +US$940.4m | 91.0% | PS1.3x | |
ELAN Elanco Animal Health | US$14.49 | 11.1% +US$716.8m | 24.7% | PS1.6x | |
RPRX Royalty Pharma | US$27.17 | 3.5% +US$407.8m | -7.4% | PE18.1x |